Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation

被引：0
|
作者：
Ozturk, C. [1 ]
Sahin, U. [2 ]
Seval, G. C. [1 ]
Bozdag, S. C. [1 ]
Toprak, S. K. [1 ]
Yuksel, M. K. [1 ]
Topcuoglu, P. [1 ]
Ozcan, M. [1 ]
Gurman, G. [1 ]
Ilhan, O. [1 ]
Arslan, O. [1 ]
机构：
[1] Ankara Univ, Ankara, Turkey
[2] Medicana Int Ankara Hosp, Ankara, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P432
引用
收藏
页码：335 / 336
页数：2
相关论文
共 50 条
  • [41] Addition of Venetoclax to Patients with Acute Myeloid Leukemia Relapsing after Treatment with Hypomethylating Agents. Multicenter Historical Prospective Study
    Ram, Ron
    Amit, Odelia
    Zuckerman, Tsila
    Gurion, Ronit
    Raanani, Pia
    Bar-On, Yael
    Avivi, Irit
    Wolach, Ofir
    BLOOD, 2018, 132
  • [42] THE TIME FACTOR AND THE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Parovichnikova, E. N.
    Kuzmina, L. A.
    Vasilyeva, V. A.
    Pokrovskaya, O. S.
    Drokov, M. Yu.
    Lukyanova, I. A.
    Fidarova, Z. T.
    Gaponova, T. V.
    Troitskaya, V. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2024, 69 (03): : 276 - 284
  • [43] Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis
    Yufeng Du
    Chunhong Li
    Zhijia Zhao
    Yikun Liu
    Chengtao Zhang
    Jinsong Yan
    BMC Cancer, 23
  • [44] Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis
    Du, Yufeng
    Li, Chunhong
    Zhao, Zhijia
    Liu, Yikun
    Zhang, Chengtao
    Yan, Jinsong
    BMC CANCER, 2023, 23 (01)
  • [45] Successful use of venetoclax combined with azacitidine in isolated extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report
    Qingqing Lin
    Peipei Ye
    Tiantian Wang
    Ying Lu
    Annals of Hematology, 2024, 103 : 335 - 337
  • [46] Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation with Venetoclax, Hypomethylating Agents and DLI - a Retrospective Multi Center Study
    Schuler, Esther
    Wagner-Drouet, Eva-Maria
    Ajib, Salem
    Bug, Gesine
    Crysandt, Martina
    Dressler, Sabine
    Hausmann, Andreas
    Heidenreich, Daniela
    Hirschbuhl, Klaus
    Hoepting, Matthias
    Jost, Edgar
    Kaivers, Jennifer
    Klein, Stefan A.
    Kordelas, Lambros
    Kriege, Oliver
    Mueller, Lutz Peter
    Rautenberg, Christina
    Schaffrath, Judith
    Schmid, Christoph
    Wolff, Daniel
    Bornhaeuser, Martin
    Schroeder, Thomas
    Kobbe, Guido
    BLOOD, 2019, 134
  • [47] Successful use of venetoclax combined with azacitidine in isolated extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report
    Lin, Qingqing
    Ye, Peipei
    Wang, Tiantian
    Lu, Ying
    ANNALS OF HEMATOLOGY, 2024, 103 (01) : 335 - 337
  • [48] The efficacy of the combination of venetoclax and hypomethylating agents versus HAG agents in patients with acute myeloid leukemia: a retrospective study
    Xin, Fei
    Yu, Yan-Hui
    Shen, Xu-Liang
    Zhang, Guo-Xiang
    HEMATOLOGY, 2024, 29 (01)
  • [49] Treatment Approaches in Acute Leukemia Patients Relapsing Following Allogeneic Hematopoietic Stem Cell Transplantation
    Topcuoglu, Pervin
    Gunduz, Mehmet
    Ozen, Mehmet
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Ilhan, Osman
    Akan, Hamdi
    Beksac, Meral
    Konuk, Nahide
    Gurman, Gunhan
    BLOOD, 2014, 124 (21)
  • [50] Hypomethylating Agents as Bridging Therapy before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myelomonocytic Leukemia?
    Robin, Marie
    Fenaux, Pierre
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (01) : 1 - 2
12345